来源:Reuters10 月 28 日(路透社)发布:据英国《金融时报》近日报道,赛默飞世尔科技正考虑以全现金方式收购美国临床试验数据管理公司Clario,这笔交易对Clario的估值约为100亿美元。此次收购将加强赛默飞世尔科技在临床试验数据管理领域的能力,进一步完善其在药物研发服务链条上的布局,有助于公司为客户提供更全面的解决方案,提升其在全球生命科学服务市场的竞争力。Clario 将获得更多...
Source Link来源:Reuters10 月 28 日(路透社)发布:据英国《金融时报》近日报道,赛默飞世尔科技正考虑以全现金方式收购美国临床试验数据管理公司Clario,这笔交易对Clario的估值约为100亿美元。此次收购将加强赛默飞世尔科技在临床试验数据管理领域的能力,进一步完善其在药物研发服务链条上的布局,有助于公司为客户提供更全面的解决方案,提升其在全球生命科学服务市场的竞争力。Clario 将获得更多...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.